Germany's Social Democratic Party (SPD) has proposed a new law that would give cancer survivors a "right to be forgotten." This means that once a doctor confirms a person has been cancer-free for a certain period — usually five years — banks, insurance companies, and adoption agencies would no longer be allowed to ask whether that person once had cancer.

The SPD is the smaller partner in Germany's coalition government. The party says the proposal addresses unfair treatment affecting an estimated 5.5 million people in Germany who have been told by their doctors that they are cancer-free. According to survey data from a patients' rights group, 77% of these survivors run into discrimination when applying for private insurance.

The proposal has strong personal backing from people in power. Adis Ahmetović, a member of the SPD's parliamentary group, was diagnosed with lymphoma (a type of blood cancer) at age 30. He is now 33 and has been tumour-free since October 2024. He said the policy "would not cost the state a cent." Lars Klingbeil, the SPD's co-leader and Germany's finance minister, was treated for tongue cancer after his diagnosis in 2014 and supports the law. Manuela Schwesig, who leads the state of Mecklenburg-Western Pomerania and is a breast cancer survivor, also backed the proposal. She said Germany lags behind other EU countries in giving former cancer patients a fresh start.

A public petition pushing Germany to adopt these reforms has gathered more than 55,000 signatures. It was started by Tobias Burggraf, whose daughter was diagnosed with cancer at two and a half years old.

The idea of a right to be forgotten for cancer survivors has been discussed in Europe before. In simple terms, it works like a legal expiration date on a cancer diagnosis — after a set number of years, the fact that someone once had cancer can no longer be used against them when they apply for a loan, buy insurance, or try to adopt a child. A 2022 review article looked at how this right works across Europe and whether the EU has the power to pass laws on it. A 2025 article in ESMO Open, written by F. André, called for fair access to financial services to end discrimination against cancer survivors.

Not everyone agrees with the proposal. The German Insurance Association (GDV) has pushed back. The group warned against setting fixed time limits, saying that insurance companies offering life and disability coverage need to assess a person's future health risk based on science and medical advice. Otherwise, they argue, policies could become more expensive for everyone. Jörg Asmussen is the GDV's general manager. Susanne Weg-Remers, who works at the German Cancer Research Centre in Heidelberg, is also connected to the debate, though her specific views are not detailed in the available reporting.

The two sides are arguing from very different places. The SPD's case is about fairness: once a person is medically cleared, a past cancer diagnosis should not follow them into banking, insurance, or adoption. The insurance industry's case is about numbers: insurance works by estimating future risk, and if cancer history cannot be considered after a fixed period, pricing models could be thrown off and costs could rise for other customers.

One reason this proposal has real momentum is that the people pushing it know the issue firsthand. A finance minister, a state premier, and a parliamentary spokesperson have all survived cancer themselves, which closes the gap between the people writing laws and the people affected by them.

The broader context here is whether that momentum can turn into actual law. That will depend on whether the parties in the coalition can agree, and whether the insurance industry will accept a compromise — perhaps rules that vary by cancer type and recurrence data, rather than the single five-year cutoff the SPD currently has in mind.